Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies

BACKGROUND: The most important prognostic factors for survival in patients with metastatic renal cell carcinoma (mRCC) were evaluated in the era of cytokine therapy, and only recently were revalidating in patients receiving targeted therapies (TTs). METHODS: Clinical data for consecutive patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Procopio, G, Verzoni, E, Iacovelli, R, Biasoni, D, Testa, I, Porcu, L, De Braud, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494435/
https://www.ncbi.nlm.nih.gov/pubmed/22968651
http://dx.doi.org/10.1038/bjc.2012.327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494435/
https://www.ncbi.nlm.nih.gov/pubmed/22968651
http://dx.doi.org/10.1038/bjc.2012.327

Ejemplares similares